Next Article in Journal
How Viruses Use the VCP/p97 ATPase Molecular Machine
Next Article in Special Issue
Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
Previous Article in Journal
Neonatal Development in Prenatally Zika Virus-Exposed Infant Macaques with Dengue Immunity
Previous Article in Special Issue
Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses
Review

The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients

1
Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland
2
Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
These authors contribute equally to this work and share the first authorship.
Academic Editors: Elizabeth M. Anderson and Sigrid Gouma
Viruses 2021, 13(9), 1879; https://doi.org/10.3390/v13091879
Received: 31 July 2021 / Revised: 13 September 2021 / Accepted: 17 September 2021 / Published: 20 September 2021
(This article belongs to the Special Issue Pre-existing Immunity Effects on Viral Infections and Vaccinations)
Since its outbreak in December 2019, the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), led to an enormous rise in scientific response with an excess of COVID-19-related studies on the pathogenesis and potential therapeutic approaches. Solid organ transplant (SOT) recipients are a heterogeneous population with long-lasting immunosuppression as a joining element. Immunocompromised patients are a vulnerable population with a high risk of severe infections and an increased infection-related mortality rate. It was postulated that the hyperinflammatory state due to cytokine release syndrome during severe COVID-19 could be alleviated by immunosuppressive therapy in SOT patients. On the other hand, it was previously established that T cell-mediated immunity, which is significantly weakened in SOT recipients, is the main component of antiviral immune responses. In this paper, we present the current state of science on COVID-19 immunology in relation to solid organ transplantation with prospective therapeutic and vaccination strategies in this population. View Full-Text
Keywords: solid organ transplant recipients; COVID-19; cellular immunity; humoral immunity; vaccination solid organ transplant recipients; COVID-19; cellular immunity; humoral immunity; vaccination
MDPI and ACS Style

Dęborska-Materkowska, D.; Kamińska, D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses 2021, 13, 1879. https://doi.org/10.3390/v13091879

AMA Style

Dęborska-Materkowska D, Kamińska D. The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients. Viruses. 2021; 13(9):1879. https://doi.org/10.3390/v13091879

Chicago/Turabian Style

Dęborska-Materkowska, Dominika, and Dorota Kamińska. 2021. "The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients" Viruses 13, no. 9: 1879. https://doi.org/10.3390/v13091879

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop